Aarhus Universitet

Region Midtjylland

Herrens Mark Aps

Liquid Vanity Aps

Stevia Limited

Per Bendix Jeppesen

Kjeld Hermansen

Dan Mønster Nielsen

Max Norman Tandrup Lambert

Soren Gregersen

Allan Korsgaard Poulsen

Søren Lavrsen

Fredrik Brustad Mellbye

Søren Gregersen

Anne Cathrine Sonderstgaard Thorup

Michael Mohr Jensen

Anne Cathrine Thorup

Max Norman Lambert

Anne Cathrine Sønderstgaard Thorup

The present invention relates to a composition comprising a mixture of a polymeric biguanide polymer and an alkyl and/or dialkyl oxyethylene methyl ammonium salt for use as a medicament, in particular for use in treating, preventing or ameliorating a fungal disease such as aspergillosis. The present invention provides a method of treating, preventing and/or ameliorating a medical condition comprising administering the composition of the present invention to a human or animal in need thereof. A mechanical device comprising said composition is also provided.

Antifungal agent

The invention relates to a composition comprising isoflavones from red clover. The red clover extract has been fermented to obtain a composition comprising aglycone isoflavones. The fermentation is preferably performed by a lactic acid bacteria or fermented dandelion extract.

Product comprising red clover extract and methods for producing the same

A method is provided of treating, preventing or ameliorating type 2 diabetes and/or a clinical condition associated with type 2 diabetes, which method comprises administering an effective amount of cafestol or a derivative thereof including esters and salts thereof to a person in need thereof. Further provided are compositions comprising cafestol and at least one additional agent suitable for treating, preventing or ameliorating diabetes and/or a clinical condition associated with diabetes. A method is also provided of increasing insulin secretion and/or increasing insulin-dependent glucose uptake, said method comprising administering an effective amount of cafestol or a derivative thereof to a person in need thereof.

Cafestol for treating diabetes

The present invention relates to compositions comprising a steviol glycoside for use in restoring muscle glycogen by increasing the rate of glycogen re-synthesis in muscles that are depleted in glycogen due to exhaustive exercise and/or for use in treatment of muscle mass by increasing the rate of protein synthesis in muscles that are depleted in protein mass.

Compositions for use in restoring muscle glycogen and/or muscle mass

A biocidal composition is provided, which comprise a mixture of the biocides Poly-(hexamethylene-guanidium chloride) and N,N-didecyl-N-methyl-poly(oxyethyl) ammonium propionate, which biocides have a synergistic biocidal effect against bacteria and fungi. Specifically, the provided composition can be as disinfectants and general biocidal products; preservatives; pest control; control; preservatives for food or feedstocks; antifouling products; embalming and taxidermist fluids; and control of other vertebrates; vermin control on domestic animals, livestock or pets; alga control; and products for use in spas or swimming pools.

Laundry detergent

A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.

Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome

The present invention relates to the use of isosteviol, steviol, and related compounds for elevating the plasma HDL-cholesterol level. The invention furthermore relates to the use of these compounds for reducing the body weight of a subject and/or lowering the plasma triglyceride level of a subject, including a concomitant elevation of the plasma HDL-cholesterol level. Preferably the compounds used are isosteviol and/or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. The compounds may furthermore be administered in combination with one or more further active compounds, such as e.g. LDL-cholesterol lowering agents. The invention furthermore relates to a method for elevating the plasma HDL-cholesterol level in a subject by administering to a subject in need of such treatment a plasma HDL-cholesterol level elevating amount of the compounds, described herein.

Growing community of inventors

Egå, Denmark

Per Bendix Jeppesen